Opioid-induced Esophageal Dysfunction Masquerading as Type I Achalasia
- PMID: 39397629
- PMCID: PMC11474562
- DOI: 10.5056/jnm24088
Opioid-induced Esophageal Dysfunction Masquerading as Type I Achalasia
Conflict of interest statement
Figures


Similar articles
-
Endoscopic ultrasound: a powerful tool to modify treatment algorithms in opioid-induced achalasia.Surg Endosc. 2021 Aug;35(8):4585-4594. doi: 10.1007/s00464-020-07882-0. Epub 2020 Aug 26. Surg Endosc. 2021. PMID: 32845401
-
Opioid-Induced Esophageal Dysfunction: Differential Effects of Type and Dose.Am J Gastroenterol. 2019 Sep;114(9):1464-1469. doi: 10.14309/ajg.0000000000000369. Am J Gastroenterol. 2019. PMID: 31403963
-
Incidence of opioid-induced esophageal dysfunction.Gastroenterol Hepatol. 2023 Apr;46(4):249-254. doi: 10.1016/j.gastrohep.2022.05.004. Epub 2022 May 20. Gastroenterol Hepatol. 2023. PMID: 35605820 English, Spanish.
-
Achalasia: new perspectives on an old disease.Neurogastroenterol Motil. 2016 Jan;28(1):4-11. doi: 10.1111/nmo.12750. Neurogastroenterol Motil. 2016. PMID: 26690870 Review.
-
Opioid-induced esophageal dysfunction.Curr Opin Gastroenterol. 2020 Jul;36(4):344-350. doi: 10.1097/MOG.0000000000000648. Curr Opin Gastroenterol. 2020. PMID: 32427604 Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources